Medtronic annual revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic Revenue Growth & History (MDT)
Medtronic reported $36.36B in revenue for fiscal 2026, an increase of 8.43% from the previous fiscal year.
View full Medtronic company overviewMedtronic annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $36.36B | $2.83B | +8.43% |
| 2025 | 2025-04-25 | $33.54B | $1.17B | +3.62% |
| 2024 | 2024-04-26 | $32.36B | $1.14B | +3.64% |
| 2023 | 2023-04-28 | $31.23B | −$459.0M | −1.45% |
| 2022 | 2022-04-29 | $31.69B | $1.57B | +5.21% |
| 2021 | 2021-04-30 | $30.12B | $1.20B | +4.16% |
| 2020 | 2020-04-24 | $28.91B | −$1.64B | −5.38% |
| 2019 | 2019-04-26 | $30.56B | $604.0M | +2.02% |
| 2018 | 2018-04-27 | $29.95B | $243.0M | +0.82% |
| 2017 | 2017-04-28 | $29.71B | $877.0M | +3.04% |
| 2016 | 2016-04-29 | $28.83B | $8.57B | +42.31% |
| 2015 | 2015-04-24 | $20.26B | $3.26B | +19.15% |
| 2014 | 2014-04-25 | $17.00B | $415.0M | +2.50% |
| 2013 | 2013-04-26 | $16.59B | — | — |
Medtronic quarterly revenue
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $9.76B | $1.18B | +13.73% |
| Q4 2026 | 2026-04-24 | $9.81B | $881.0M | +9.87% |
| Q3 2026 | 2026-01-31 | $9.02B | $725.0M | +8.74% |
| Q3 2026 | 2026-01-23 | $9.02B | $725.0M | +8.74% |
| Q2 2026 | 2025-10-24 | $8.96B | $558.0M | +6.64% |
| Q1 2026 | 2025-07-25 | $8.58B | $663.0M | +8.38% |
| Q4 2025 | 2025-04-25 | $8.93B | $338.0M | +3.94% |
| Q3 2025 | 2025-01-24 | $8.29B | $203.0M | +2.51% |
| Q2 2025 | 2024-10-25 | $8.40B | $419.0M | +5.25% |
| Q1 2025 | 2024-07-26 | $7.92B | $213.0M | +2.77% |
| Q4 2024 | 2024-04-26 | $8.59B | $45.0M | +0.53% |
| Q3 2024 | 2024-01-26 | $8.09B | $362.0M | +4.68% |
| Q2 2024 | 2023-10-27 | $7.98B | $399.0M | +5.26% |
| Q1 2024 | 2023-07-28 | $7.70B | $331.0M | +4.49% |
| Q4 2023 | 2023-04-28 | $8.54B | $455.0M | +5.62% |
| Q3 2023 | 2023-01-27 | $7.73B | −$36.0M | −0.46% |
| Q2 2023 | 2022-10-28 | $7.58B | −$262.0M | −3.34% |
| Q1 2023 | 2022-07-29 | $7.37B | −$616.0M | −7.71% |
| Q4 2022 | 2022-04-29 | $8.09B | −$99.0M | −1.21% |
| Q3 2022 | 2022-01-28 | $7.76B | −$12.0M | −0.15% |
| Q2 2022 | 2021-10-29 | $7.85B | $200.0M | +2.62% |
| Q1 2022 | 2021-07-30 | $7.99B | $1.48B | +22.74% |
| Q4 2021 | 2021-04-30 | $8.19B | $2.19B | +36.51% |
| Q3 2021 | 2021-01-29 | $7.78B | $58.0M | +0.75% |
| Q2 2021 | 2020-10-30 | $7.65B | −$59.0M | −0.77% |
| Q1 2021 | 2020-07-31 | $6.51B | −$986.0M | −13.16% |
| Q4 2020 | 2020-04-24 | $6.00B | −$2.15B | −26.37% |
| Q3 2020 | 2020-01-24 | $7.72B | $171.0M | +2.27% |
| Q2 2020 | 2019-10-25 | $7.71B | $225.0M | +3.01% |
| Q1 2020 | 2019-07-26 | $7.49B | $109.0M | +1.48% |
| Q4 2019 | 2019-04-26 | $8.15B | $2.0M | +0.02% |
| Q3 2019 | 2019-01-25 | $7.55B | $177.0M | +2.40% |
| Q2 2019 | 2018-10-26 | $7.48B | $431.0M | +6.11% |
| Q1 2019 | 2018-07-27 | $7.38B | −$6.0M | −0.08% |
| Q4 2018 | 2018-04-27 | $8.14B | $228.0M | +2.88% |
| Q3 2018 | 2018-01-26 | $7.37B | $86.0M | +1.18% |
| Q2 2018 | 2017-10-27 | $7.05B | −$295.0M | −4.02% |
| Q1 2018 | 2017-07-28 | $7.39B | $224.0M | +3.13% |
| Q4 2017 | 2017-04-28 | $7.92B | $349.0M | +4.61% |
| Q3 2017 | 2017-01-27 | $7.28B | $349.0M | +5.03% |
| Q2 2017 | 2016-10-28 | $7.34B | $287.0M | +4.07% |
| Q1 2017 | 2016-07-29 | $7.17B | −$108.0M | −1.48% |
| Q4 2016 | 2016-04-29 | $7.57B | $263.0M | +3.60% |
| Q3 2016 | 2016-01-29 | $6.93B | $2.62B | +60.58% |
| Q2 2016 | 2015-10-30 | $7.06B | $2.69B | +61.66% |
| Q1 2016 | 2015-07-31 | $7.27B | $3.00B | +70.23% |
| Q4 2015 | 2015-04-24 | $7.30B | $2.74B | +59.96% |
| Q3 2015 | 2015-01-23 | $4.32B | $155.0M | +3.72% |
| Q2 2015 | 2014-10-24 | $4.37B | $172.0M | +4.10% |
| Q1 2015 | 2014-07-25 | $4.27B | $190.0M | +4.65% |
| Q4 2014 | 2014-04-25 | $4.57B | — | — |
| Q3 2014 | 2014-01-24 | $4.16B | — | — |
| Q2 2014 | 2013-10-25 | $4.19B | — | — |
| Q1 2014 | 2013-07-26 | $4.08B | — | — |
Medtronic revenue growth trends
Over the last five reported fiscal years, revenue grew from $30.12B to $36.36B, a compound annual growth rate of 3.84%. Medtronic's latest reported quarter, Q1 2027, generated $9.76B in revenue, an increase of 13.73% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Medtronic source filings ↗Community posts
Medtronic gains cardiac-software clearances across two ablation platforms
Medtronic ($MDT) obtained FDA clearance and a European CE mark for its latest Affera Prism-2 cardiac mapping software, alongside a CE mark for the PulseSelect ProxBox adapter and Proximity Indicator software. The Affera upgrade adds tools f ...
Medtronic’s GI Genius system shows gains in large clinical-practice study
Cosmo reported new results for GI Genius, the AI-assisted endoscopy system it develops and Medtronic ($MDT) commercializes. The cluster-randomized quality-improvement study covered more than 334,000 colonoscopies across 139 US Veterans Heal ...
Medtronic wins FDA clearance for LigaSure instrument on Hugo robot
Medtronic ($MDT) received FDA clearance for the LigaSure RAS Maryland jaw instrument for its Hugo robotic-assisted surgery system. The instrument brings the company’s vessel-sealing technology to the robotic platform and is designed to seal ...
Medtronic launches MiniMed share-exchange offer
Medtronic ($MDT) launched an exchange offer to split off at least 80.1% of MiniMed ($MMED), its former diabetes business. Investors can voluntarily exchange Medtronic shares for MiniMed stock at a 7% discount, subject to a cap of 4.5939 Min ...
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...
